Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the ...

Q3 2024 Earnings Call Transcript November 4, 2024 Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like ...

Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down while saving money ...

By getting their drugs off the shortage list, Lilly and Novo aim to curtail the market of online pharmacies such as Hims & Hers (HIMS.N), opens new tab ... U.S. could be taking compounded versions of ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

By getting their drugs off the shortage list, Lilly and Novo aim to curtail the market of online pharmacies such as Hims & ...

With the cost of GLP-1s rising for employers, so-called compounded weight-loss drugs have emerged as a more cost-conscious ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today released a white paper ...

Metformin: Typically used to treat type 2 diabetes, metformin helps control the amount of glucose in a person’s bloodstream.

New guidelines from the American Stroke Association reveal that the Mediterranean diet can reduce the risk of stroke​.

Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...

Ozempic is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help with blood sugar control ...